NKTR logo

Nektar Therapeutics (NKTR) Operating profit

annual operating profit:

-$129.92M+$5.31M(+3.92%)
December 31, 2024

Summary

  • As of today (September 16, 2025), NKTR annual operating income is -$129.92 million, with the most recent change of +$5.31 million (+3.92%) on December 31, 2024.
  • During the last 3 years, NKTR annual operating profit has risen by +$316.19 million (+70.88%).
  • NKTR annual operating profit is now -118.89% below its all-time high of $687.93 million, reached on December 31, 2018.

Performance

NKTR Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

quarterly operating profit:

-$35.78M+$8.58M(+19.35%)
June 30, 2025

Summary

  • As of today (September 16, 2025), NKTR quarterly operating income is -$35.78 million, with the most recent change of +$8.58 million (+19.35%) on June 30, 2025.
  • Over the past year, NKTR quarterly operating profit has increased by +$702.00 thousand (+1.92%).
  • NKTR quarterly operating profit is now -103.68% below its all-time high of $973.60 million, reached on June 30, 2018.

Performance

NKTR quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

TTM operating profit:

-$139.13M+$702.00K(+0.50%)
June 30, 2025

Summary

  • As of today (September 16, 2025), NKTR TTM operating income is -$139.13 million, with the most recent change of +$702.00 thousand (+0.50%) on June 30, 2025.
  • Over the past year, NKTR TTM operating profit has dropped by -$4.03 million (-2.98%).
  • NKTR TTM operating profit is now -114.67% below its all-time high of $948.29 million, reached on June 30, 2018.

Performance

NKTR TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

NKTR Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.9%+1.9%-3.0%
3 y3 years+70.9%+23.5%+64.2%
5 y5 years+70.5%+54.0%+62.9%

NKTR Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+70.9%-45.0%+23.5%-7.1%+64.2%
5 y5-yearat high+70.9%-45.0%+68.9%-7.1%+69.2%
alltimeall time-118.9%+70.9%-103.7%+70.3%-114.7%+69.2%

NKTR Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$35.78M(-19.3%)
-$139.13M(-0.5%)
Mar 2025
-
-$44.37M(+79.8%)
-$139.83M(+7.6%)
Dec 2024
-$129.92M(-3.9%)
-$24.68M(-28.0%)
-$129.92M(-4.4%)
Sep 2024
-
-$34.30M(-6.0%)
-$135.90M(+0.6%)
Jun 2024
-
-$36.48M(+5.9%)
-$135.10M(+1.8%)
Mar 2024
-
-$34.45M(+12.4%)
-$132.66M(-1.9%)
Dec 2023
-$135.22M(-43.7%)
-$30.66M(-8.5%)
-$135.22M(-7.0%)
Sep 2023
-
-$33.50M(-1.6%)
-$145.45M(-2.7%)
Jun 2023
-
-$34.05M(-8.0%)
-$149.42M(-7.9%)
Mar 2023
-
-$37.02M(-9.5%)
-$162.17M(-32.5%)
Dec 2022
-$240.24M(-46.1%)
-$40.89M(+9.1%)
-$240.24M(-23.1%)
Sep 2022
-
-$37.47M(-19.9%)
-$312.26M(-19.6%)
Jun 2022
-
-$46.79M(-59.3%)
-$388.38M(-14.0%)
Mar 2022
-
-$115.08M(+1.9%)
-$451.80M(+1.3%)
Dec 2021
-$446.10M(+17.4%)
-$112.91M(-0.6%)
-$446.10M(+0.5%)
Sep 2021
-
-$113.60M(+3.1%)
-$443.91M(+2.4%)
Jun 2021
-
-$110.20M(+0.7%)
-$433.37M(+8.1%)
Mar 2021
-
-$109.39M(-1.2%)
-$400.87M(+5.5%)
Dec 2020
-$379.92M(-13.7%)
-$110.72M(+7.4%)
-$379.92M(+0.3%)
Sep 2020
-
-$103.05M(+32.6%)
-$378.84M(+1.2%)
Jun 2020
-
-$77.71M(-12.1%)
-$374.53M(-8.2%)
Mar 2020
-
-$88.44M(-19.3%)
-$407.79M(-7.3%)
Dec 2019
-$440.04M(-164.0%)
-$109.64M(+11.0%)
-$440.04M(+2.2%)
Sep 2019
-
-$98.74M(-11.0%)
-$430.69M(+0.0%)
Jun 2019
-
-$110.97M(-8.1%)
-$430.59M(-165.8%)
Mar 2019
-
-$120.69M(+20.3%)
$653.98M(-4.9%)
Dec 2018
$687.93M(-1675.6%)
-$100.30M(+1.7%)
$687.93M(-11.8%)
Sep 2018
-
-$98.63M(-110.1%)
$780.17M(-17.7%)
Jun 2018
-
$973.60M(-1222.4%)
$948.29M(-1348.4%)
Mar 2018
-
-$86.74M(+977.1%)
-$75.96M(+74.0%)
Dec 2017
-$43.66M(-61.3%)
-$8.05M(-111.6%)
-$43.66M(-35.6%)
Sep 2017
-
$69.48M(-237.2%)
-$67.75M(-60.2%)
Jun 2017
-
-$50.66M(-6.9%)
-$170.14M(+7.8%)
Mar 2017
-
-$54.44M(+69.4%)
-$157.81M(+39.8%)
Dec 2016
-$112.86M(+284.2%)
-$32.14M(-2.3%)
-$112.85M(+2.5%)
Sep 2016
-
-$32.90M(-14.2%)
-$110.07M(+43.4%)
Jun 2016
-
-$38.33M(+304.1%)
-$76.75M(-6.3%)
Mar 2016
-
-$9.48M(-67.7%)
-$81.90M(+178.8%)
Dec 2015
-$29.37M(+78.2%)
-$29.36M(-7108.1%)
-$29.37M(-21.7%)
Sep 2015
-
$419.00K(-101.0%)
-$37.49M(-188.4%)
Jun 2015
-
-$43.47M(-201.0%)
$42.41M(-32.6%)
Mar 2015
-
$43.04M(-214.8%)
$62.96M(-481.9%)
Dec 2014
-$16.48M(-86.3%)
-$37.49M(-146.7%)
-$16.48M(+10.7%)
Sep 2014
-
$80.32M(-450.5%)
-$14.89M(-85.4%)
Jun 2014
-
-$22.92M(-37.0%)
-$101.74M(-8.7%)
Mar 2014
-
-$36.40M(+1.4%)
-$111.43M(-7.2%)
Dec 2013
-$120.13M(-13.9%)
-$35.89M(+450.1%)
-$120.13M(-5.9%)
Sep 2013
-
-$6.53M(-80.0%)
-$127.61M(-17.1%)
Jun 2013
-
-$32.60M(-27.7%)
-$153.99M(+3.8%)
Mar 2013
-
-$45.10M(+4.0%)
-$148.37M(+6.3%)
Dec 2012
-$139.53M(+12.6%)
-$43.38M(+31.9%)
-$139.53M(+6.8%)
Sep 2012
-
-$32.90M(+21.9%)
-$130.61M(+9.7%)
Jun 2012
-
-$26.99M(-25.6%)
-$119.05M(-5.8%)
Mar 2012
-
-$36.26M(+5.2%)
-$126.33M(+1.9%)
Dec 2011
-$123.94M(+690.5%)
-$34.47M(+61.5%)
-$123.94M(+27.2%)
Sep 2011
-
-$21.34M(-37.7%)
-$97.43M(+18.4%)
Jun 2011
-
-$34.26M(+1.2%)
-$82.32M(+78.2%)
Mar 2011
-
-$33.87M(+325.3%)
-$46.19M(+194.6%)
Dec 2010
-$15.68M(-83.5%)
-$7.96M(+27.9%)
-$15.68M(+18.7%)
Sep 2010
-
-$6.22M(-433.4%)
-$13.21M(-63.1%)
Jun 2010
-
$1.87M(-155.6%)
-$35.84M(-47.4%)
Mar 2010
-
-$3.36M(-38.9%)
-$68.19M(-28.3%)
Dec 2009
-$95.13M
-$5.50M(-81.0%)
-$95.13M(+55.9%)
DateAnnualQuarterlyTTM
Sep 2009
-
-$28.86M(-5.3%)
-$61.02M(-8.5%)
Jun 2009
-
-$30.48M(+0.6%)
-$66.72M(-4.1%)
Mar 2009
-
-$30.30M(-205.9%)
-$69.60M(-14.3%)
Dec 2008
-$81.19M(+124.6%)
$28.61M(-182.8%)
-$81.19M(+12.1%)
Sep 2008
-
-$34.56M(+3.6%)
-$72.43M(+26.1%)
Jun 2008
-
-$33.36M(-20.4%)
-$57.44M(+10.3%)
Mar 2008
-
-$41.89M(-212.1%)
-$52.07M(+44.0%)
Dec 2007
-$36.15M(-77.3%)
$37.38M(-291.0%)
-$36.15M(-68.2%)
Sep 2007
-
-$19.57M(-30.1%)
-$113.69M(-2.7%)
Jun 2007
-
-$27.99M(+7.8%)
-$116.80M(-23.2%)
Mar 2007
-
-$25.97M(-35.3%)
-$152.03M(-4.5%)
Dec 2006
-$159.23M(-8.9%)
-$40.16M(+77.1%)
-$159.23M(-27.6%)
Sep 2006
-
-$22.68M(-64.1%)
-$219.93M(-0.3%)
Jun 2006
-
-$63.21M(+90.5%)
-$220.62M(+20.0%)
Mar 2006
-
-$33.17M(-67.1%)
-$183.86M(+5.2%)
Dec 2005
-$174.77M(+136.4%)
-$100.86M(+331.7%)
-$174.77M(+89.3%)
Sep 2005
-
-$23.37M(-11.7%)
-$92.31M(+5.2%)
Jun 2005
-
-$26.45M(+9.8%)
-$87.77M(+6.5%)
Mar 2005
-
-$24.09M(+30.9%)
-$82.44M(+11.2%)
Dec 2004
-$73.94M(+11.7%)
-$18.40M(-2.3%)
-$74.15M(-2.0%)
Sep 2004
-
-$18.83M(-10.8%)
-$75.66M(+6.6%)
Jun 2004
-
-$21.12M(+33.6%)
-$70.97M(+10.1%)
Mar 2004
-
-$15.81M(-20.6%)
-$64.45M(-2.6%)
Dec 2003
-$66.19M(-33.9%)
-$19.91M(+40.9%)
-$66.19M(-12.4%)
Sep 2003
-
-$14.13M(-3.2%)
-$75.52M(-12.2%)
Jun 2003
-
-$14.60M(-16.7%)
-$85.97M(-8.6%)
Mar 2003
-
-$17.54M(-40.0%)
-$94.04M(-6.0%)
Dec 2002
-$100.08M(-9.6%)
-$29.24M(+19.0%)
-$100.08M(-3.4%)
Sep 2002
-
-$24.58M(+8.4%)
-$103.64M(-3.6%)
Jun 2002
-
-$22.68M(-3.8%)
-$107.55M(-3.1%)
Mar 2002
-
-$23.58M(-28.1%)
-$111.01M(+0.3%)
Dec 2001
-$110.70M(+73.4%)
-$32.80M(+15.1%)
-$110.70M(+15.6%)
Sep 2001
-
-$28.49M(+9.0%)
-$95.73M(+15.1%)
Jun 2001
-
-$26.14M(+12.3%)
-$83.18M(+15.0%)
Mar 2001
-
-$23.27M(+30.5%)
-$72.35M(+13.3%)
Dec 2000
-$63.85M(+108.7%)
-$17.84M(+11.9%)
-$63.85M(+13.8%)
Sep 2000
-
-$15.94M(+4.2%)
-$56.09M(+17.3%)
Jun 2000
-
-$15.30M(+3.6%)
-$47.82M(+22.2%)
Mar 2000
-
-$14.77M(+46.6%)
-$39.12M(+28.1%)
Dec 1999
-$30.59M(+39.1%)
-$10.08M(+31.4%)
-$30.55M(+12.1%)
Sep 1999
-
-$7.67M(+16.2%)
-$27.26M(+7.4%)
Jun 1999
-
-$6.60M(+6.5%)
-$25.39M(+11.5%)
Mar 1999
-
-$6.20M(-8.7%)
-$22.78M(+4.2%)
Dec 1998
-$21.99M(+60.2%)
-$6.79M(+17.1%)
-$21.86M(+12.9%)
Sep 1998
-
-$5.80M(+45.3%)
-$19.37M(+13.7%)
Jun 1998
-
-$3.99M(-24.4%)
-$17.03M(+4.9%)
Mar 1998
-
-$5.28M(+22.7%)
-$16.23M(+18.5%)
Dec 1997
-$13.72M(+19.3%)
-$4.30M(+24.1%)
-$13.69M(+3.8%)
Sep 1997
-
-$3.46M(+8.6%)
-$13.20M(+6.1%)
Jun 1997
-
-$3.19M(+16.2%)
-$12.43M(+1.5%)
Mar 1997
-
-$2.74M(-27.8%)
-$12.24M(+5.6%)
Dec 1996
-$11.50M(+30.7%)
-$3.80M(+40.7%)
-$11.60M(+12.6%)
Sep 1996
-
-$2.70M(-10.0%)
-$10.30M(+7.3%)
Jun 1996
-
-$3.00M(+42.9%)
-$9.60M(+11.6%)
Mar 1996
-
-$2.10M(-16.0%)
-$8.60M(-2.3%)
Dec 1995
-$8.80M(+54.4%)
-$2.50M(+25.0%)
-$8.80M(+1.1%)
Sep 1995
-
-$2.00M(0.0%)
-$8.70M(+11.5%)
Jun 1995
-
-$2.00M(-13.0%)
-$7.80M(+13.0%)
Mar 1995
-
-$2.30M(-4.2%)
-$6.90M(+23.2%)
Dec 1994
-$5.70M
-$2.40M(+118.2%)
-$5.60M(+75.0%)
Sep 1994
-
-$1.10M(0.0%)
-$3.20M(+52.4%)
Jun 1994
-
-$1.10M(+10.0%)
-$2.10M(+110.0%)
Mar 1994
-
-$1.00M
-$1.00M

FAQ

  • What is Nektar Therapeutics annual operating income?
  • What is the all time high annual operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics annual operating profit year-on-year change?
  • What is Nektar Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly operating profit year-on-year change?
  • What is Nektar Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics TTM operating profit year-on-year change?

What is Nektar Therapeutics annual operating income?

The current annual operating profit of NKTR is -$129.92M

What is the all time high annual operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high annual operating income is $687.93M

What is Nektar Therapeutics annual operating profit year-on-year change?

Over the past year, NKTR annual operating income has changed by +$5.31M (+3.92%)

What is Nektar Therapeutics quarterly operating income?

The current quarterly operating profit of NKTR is -$35.78M

What is the all time high quarterly operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly operating income is $973.60M

What is Nektar Therapeutics quarterly operating profit year-on-year change?

Over the past year, NKTR quarterly operating income has changed by +$702.00K (+1.92%)

What is Nektar Therapeutics TTM operating income?

The current TTM operating profit of NKTR is -$139.13M

What is the all time high TTM operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high TTM operating income is $948.29M

What is Nektar Therapeutics TTM operating profit year-on-year change?

Over the past year, NKTR TTM operating income has changed by -$4.03M (-2.98%)
On this page